ARCHIVES

Roferon A Application Marred By Mission Data, Protocol, Compliance

This article is from The Cancer Letter archive.

Vol. 25 No. 36 | September 24, 1999

Download PDF Visit The Full Archive

Related Articles

Enzastaurin Shows Activity In Recurrent High-Grade Glioma

June 24, 2005

NCI Revises Procedure for Contract Concept Review By Advisors

September 6, 1996

As Amgen, Johnson & Johnson Battle Over Anemia Market, Medicare Enters The Fray

December 13, 2002

Study Identifies Risk Factors To Predict Contralateral Cancer

February 27, 2009

Friends Of Cancer Research Plan September Launch

August 9, 1996

Congressional Panel Is Investigating FDA Oversight Of Generic Cancer Drugs

August 18, 1995